Immunology and Microbiology
Immunotherapy
46%
Interferon Type I
42%
Immune Checkpoint Blockade
41%
Cytotoxic T-Cell
38%
Neoantigen
38%
Tumor Antigen
37%
Hepatitis C Virus
34%
Cyclophosphamide
34%
Cancer Immunotherapy
31%
Tumor Cell
28%
Tumor Immunology
26%
Immunocompetent Cell
26%
T-Helper Cell
22%
Virus Core
20%
Regulatory T Cell
19%
T Cell
18%
Virus
18%
Immune System
18%
Cross-Presentation
17%
Ecotropic Virus
17%
Mediator
17%
Antigen Specificity
17%
Tumor Necrosis Factor Alpha
17%
Cell Population
17%
Real Time Polymerase Chain Reaction
17%
Defective Interfering Particle
17%
Reverse Transcription Polymerase Chain Reaction
17%
Peripheral Blood Mononuclear Cell
17%
Tumor-Infiltrating Lymphocytes
17%
Metabolite
17%
Lymphocyte
17%
Gene Expression
15%
Immunodeficiency
14%
Cytotoxic T Cell
13%
Murine
13%
Immune Response
13%
Peptides
12%
Cytomegalovirus
11%
Interferon Gamma
11%
Lymphoid Organ
11%
Cell Death
11%
Cytokine
9%
Cell Nucleus Antigen
8%
RNA Sequence
8%
Helper Virus
8%
Lymphocyte Proliferation
8%
Murine Leukemia Virus
8%
Blood Vessels
8%
Effector Cell
8%
DNA Virus
8%
Medicine and Dentistry
Neoplasm
94%
Mesothelioma
59%
Immune Checkpoint Blockade
47%
Malignant Neoplasm
45%
Immunotherapy
39%
Cytotoxic T-Cell
36%
Tumor Microenvironment
28%
Lung Cancer
26%
Tumor Vaccine
24%
Diseases
22%
Lymph Node
22%
Immune Response
20%
Primary Tumor
17%
Cancer Immunization
17%
Cytoreductive Surgery
17%
Lung Metastasis
17%
Cancer Chemotherapy
17%
Thoracic Cancer
17%
Public Health
17%
Tumor Immunology
17%
Debulking Surgery
17%
Retroperitoneal Lymph Node Dissection
17%
Cyclophosphamide
17%
Tretinoin
17%
Hepatitis C Virus
17%
Antimetabolite
17%
Tumor Infiltrating Lymphocyte
17%
Lymphocyte
17%
Cancer
13%
Tumor Progression
12%
Cancer Model
11%
CTLA-4
11%
Tumor Model
10%
Immune System
9%
Cancer Cell
9%
Metastatic Carcinoma
8%
Tumor Immunity
8%
Treatment Response
8%
Immunocompetent Cell
8%
CD8 Antigen
8%
Tumor Regression
7%
T-Helper Cell
7%
Gene Expression
7%
Cancer Immunotherapy
6%
Combination Therapy
6%
Proteus Syndrome
6%
Clinical Trial
6%
Vaccine Efficacy
5%
Cell Population
5%
Chemotherapy Agent
5%
Biochemistry, Genetics and Molecular Biology
Immune Checkpoints
100%
T Cell
36%
Genetics
34%
CD8
34%
Clinical Trial
26%
Cancer Model
26%
Animal Models
25%
Immunocompetent Cell
21%
Immune Response
19%
Genetic Divergence
19%
Cancer Cell
17%
Cyclophosphamide
17%
Mediator
17%
Tumor-Infiltrating Lymphocytes
17%
Cancer Immunotherapy
17%
Antigen Specificity
17%
Tretinoin
17%
Lymphocyte
17%
Gene Signature
17%
Hub Genes
17%
Transcriptomics
17%
Survival Prediction
17%
Anticancer
17%
CTLA-4
15%
Tumor Antigen
15%
Modifier Gene
13%
Gene Expression
13%
Gene Expression Profiling
13%
Mouse Model
12%
Murine
12%
Antigen Recognition
8%
Mesenchymal-Epithelial Transition
8%
Differential Gene Expression
8%
Overall Survival
6%
Quantitative Trait Locus
6%
Genetic Variation
6%
Genetic Determinism
6%
CD4
5%
Regulatory T Cell
5%
Fluorouracil
5%
PD-L1
5%